Greenland Mines Ltd, formerly known as Klotho Neurosciences, Inc., reported significant financial changes in its latest 10-Q filing for the quarter ending March 31, 2026. The company recorded a net loss of $13.9 million, a substantial increase from the $2.1 million loss reported in the same period last year. This increase in losses is attributed to heightened operating expenses, which surged to $9.5 million from $1.6 million year-over-year, primarily driven by increased professional fees and general administrative costs associated with its transition to a public company following a recent merger.

The company’s total assets rose dramatically to $59.7 million as of March 31, 2026, compared to $9.6 million at the end of 2025. This increase is largely due to the acquisition of Greenland Mines Corp., which provided the company with significant mineral rights and exploratory licenses related to the Skaergaard Project in Greenland. The acquisition, completed on March 4, 2026, was valued at approximately $48.4 million and has positioned the company to operate in both the biotech and mining sectors.

In terms of operational metrics, Greenland Mines reported a cash balance of $10 million at the end of the quarter, up from $7.2 million at the end of 2025. The company’s employee headcount has also increased, reflecting its expanded operational scope. The merger has allowed Greenland Mines to diversify its business model, focusing on both biotechnology research and mineral exploration, which is expected to enhance its market presence and growth potential.

The company has indicated that it is in a pre-revenue state, with no revenue generated during the reported periods. The management has expressed concerns regarding its ability to continue as a going concern, citing the need for additional funding to support ongoing operations and development plans. The company is actively seeking to raise capital through equity and debt securities to sustain its business activities.

Looking ahead, Greenland Mines aims to leverage its new mining segment to explore and develop the Skaergaard Project, which is one of the largest undeveloped palladium, gold, and platinum deposits globally. The company’s strategic focus will remain on advancing its exploration efforts while managing its operational costs effectively. The management is optimistic about the potential of its dual business model to drive future growth and shareholder value.

About Greenland Mines Ltd

Klotho Neurosciences develops innovative cell and gene therapies targeting age-related neurodegenerative diseases like Alzheimer's and ALS. Its proprietary platforms include gene therapy approaches to increase Klotho protein levels, aiming to prevent neuronal decline and improve cognitive function. The company also licenses biosimilar biologics and generic drugs for cancer treatment, focusing on advancing therapies that address aging and chronic diseases in global markets.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov